Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature

The optimal second- and third-line chemotherapy and targeted therapy for patients with advanced esophagogastric cancer is still a matter of debate. Therefore, a literature search was carried out in Medline, EMBASE, CENTRAL, and oncology conferences until January 2016 for randomized controlled trials...

Descripción completa

Detalles Bibliográficos
Autores principales: ter Veer, Emil, Haj Mohammad, Nadia, van Valkenhoef, Gert, Ngai, Lok Lam, Mali, Rosa M. A., van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035657/
https://www.ncbi.nlm.nih.gov/pubmed/27417221
http://dx.doi.org/10.1007/s10555-016-9632-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035657/
https://www.ncbi.nlm.nih.gov/pubmed/27417221
http://dx.doi.org/10.1007/s10555-016-9632-2

Ejemplares similares